Skip to main content

Anti-MyD88 antibody (ab2064) is a rabbit polyclonal antibody detecting MyD88 in Western Blot, IHC-P, ICC/IF. Suitable for Human, Mouse.



- KO validated for confirmed specificity

- Over 140 publications

- Trusted since 2000


Images

Western blot - Anti-MyD88 antibody (AB2064), expandable thumbnail
  • Western blot - Anti-MyD88 antibody (AB2064), expandable thumbnail
  • Western blot - Anti-MyD88 antibody (AB2064), expandable thumbnail
  • Immunocytochemistry/ Immunofluorescence - Anti-MyD88 antibody (AB2064), expandable thumbnail
  • Immunocytochemistry/ Immunofluorescence - Anti-MyD88 antibody (AB2064), expandable thumbnail

Publications

Key facts

Isotype
IgG
Host species
Rabbit
Storage buffer

pH: 7.2
Preservative: 0.02% Sodium azide

Form
Liquid
Clonality
Polyclonal

Immunogen

  • Synthetic Peptide within Human MYD88 aa 250 to C-terminus. The exact immunogen used to generate this antibody is proprietary information. Database link Q99836

Consider this alternative

Reactivity data

Select an application
Product promiseTestedExpectedPredictedNot recommended
IHC-PWBICC/IF
Human
Tested
Tested
Tested
Mouse
Tested
Expected
Expected

Tested
Tested

Species
Human
Dilution info
10-20 µg/mL
Notes

-

Species
Mouse
Dilution info
10-20 µg/mL
Notes

-

Tested
Tested

Species
Human
Dilution info
1/500.00000 - 1/1000.00000
Notes

-

Expected
Expected

Species
Mouse
Dilution info
Use at an assay dependent concentration.
Notes

-

Tested
Tested

Species
Human
Dilution info
20 µg/mL
Notes

-

Expected
Expected

Species
Mouse
Dilution info
Use at an assay dependent concentration.
Notes

-

Associated Products

Select an associated product type

4 products for Alternative Product

Target data

Function

Adapter protein involved in the Toll-like receptor and IL-1 receptor signaling pathway in the innate immune response (PubMed:15361868, PubMed:18292575, PubMed:33718825, PubMed:37971847). Acts via IRAK1, IRAK2, IRF7 and TRAF6, leading to NF-kappa-B activation, cytokine secretion and the inflammatory response (PubMed:15361868, PubMed:19506249, PubMed:24316379). Increases IL-8 transcription (PubMed:9013863). Involved in IL-18-mediated signaling pathway. Activates IRF1 resulting in its rapid migration into the nucleus to mediate an efficient induction of IFN-beta, NOS2/INOS, and IL12A genes. Upon TLR8 activation by GU-rich single-stranded RNA (GU-rich RNA) derived from viruses such as SARS-CoV-2, SARS-CoV and HIV-1, induces IL1B release through NLRP3 inflammasome activation (PubMed:33718825). MyD88-mediated signaling in intestinal epithelial cells is crucial for maintenance of gut homeostasis and controls the expression of the antimicrobial lectin REG3G in the small intestine (By similarity).

Alternative names

Recommended products

Anti-MyD88 antibody (ab2064) is a rabbit polyclonal antibody detecting MyD88 in Western Blot, IHC-P, ICC/IF. Suitable for Human, Mouse.



- KO validated for confirmed specificity

- Over 140 publications

- Trusted since 2000

Key facts

Isotype
IgG
Form
Liquid
Clonality
Polyclonal
Immunogen
  • Synthetic Peptide within Human MYD88 aa 250 to C-terminus. The exact immunogen used to generate this antibody is proprietary information. Database link Q99836
Purification technique
Affinity purification Immunogen
Concentration
Loading...

Storage

Shipped at conditions
Blue Ice
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
-20°C
Aliquoting information
Upon delivery aliquot
Storage information
Avoid freeze / thaw cycle

Notes

What is this antibody validated in?


Anti-MyD88 antibody (ab2064) is a rabbit polyclonal antibody and is validated for use in Western Blot (WB), Immunohistochemistry (IHC-P), Immunocytochemistry/immunofluorescence (ICC/IF) in Human, Mouse samples.

What is the molecular weight of MyD88?


Anti-MyD88 (ab2064) specifically detects a band for MyD88 (UniProt: Q99836) at a molecular weight of 33kDa.

Trusted by the scientific community


Anti-MyD88 (ab2064) was first used in a scientific publication in 2000 and has been cited over 140 times in peer-reviewed journals.

Reviewed by scientists


Anti-MyD88 (ab2064) has over 10 independent reviews from customers.

Specificity confirmed


The specificity of Anti-MyD88 antibody (ab2064) has been confirmed by Western blot testing in MYD88 Knockout A549 cell line, Human MYD88 knockout A549 cell line ab286715.



Supplementary info

This supplementary information is collated from multiple sources and compiled automatically.
Activity summary

MyD88 standing for myeloid differentiation primary response 88 is a cytoplasmic adaptor protein with a molecular weight of approximately 33 kDa. This protein is expressed widely in immune cells including monocytes macrophages and dendritic cells. MyD88 serves a major role in the signaling pathways for the innate immune system. It acts as a linker transmitting signals from toll-like receptors (TLRs) and interleukin-1 receptors (IL-1Rs) to downstream signaling molecules ultimately activating transcription factors.

Biological function summary

MyD88 plays a significant role in mediating immune responses by forming part of a complex that includes IRAK kinases and TRAF6. When TLRs or IL-1Rs activate MyD88 this adaptor protein recruits IRAK4 which then phosphorylates IRAK1 or IRAK2. This cascade promotes the activation of NF-κB and MAPK pathways leading to the production of inflammatory cytokines. The MyD88-dependent pathway is integral to innate immunity influencing how the body responds to pathogen infection and inflammation.

Pathways

MyD88 integrates into both the TLR signaling and IL-1R signaling pathways. Key related proteins in these pathways include interleukin-1 receptor-associated kinase (IRAK) and tumor necrosis factor receptor-associated factor 6 (TRAF6). MyD88 initiates the recruitment and activation of IRAK1 and IRAK4 following receptor engagement leading to subsequent activation of downstream signals. As part of these pathways MyD88 mediates cellular responses important for immune system signaling and inflammatory response regulation.

Associated diseases and disorders

MyD88 involvement is notable in the context of oncological and autoimmune diseases. Mutations or dysregulation of MyD88 are implicated in conditions like lymphoma and rheumatoid arthritis. In lymphoma the mutation usually results in constant activation of NF-κB leading to unchecked cell growth. As for rheumatoid arthritis an overactive immune response due to MyD88 can cause additional inflammation affecting joint tissues. In these conditions MyD88 interaction with IRAK4 is significant given their mutual role in immune and inflammatory pathways.

Product promise

We are dedicated to supporting your work with high quality reagents and we are here for you every step of the way should you need us.

In the unlikely event of one of our products not working as expected, you are covered by our product promise.

Full details and terms and conditions can be found here:
Terms & Conditions.

10 product images

  • Western blot - Anti-MyD88 antibody (ab2064), expandable thumbnail

    Western blot - Anti-MyD88 antibody (ab2064)

    Western blot: Anti-MYD88 antibody (ab2064) staining at 1/1000 dilution, shown in green; Mouse anti-CANX [CANX/1543] (Anti-Calnexin antibody [CANX/1543] ab238078) loading control staining at 1/20000 dilution, shown in red. In Western blot, ab2064 was shown to bind specifically to MYD88. A band was observed at 35 kDa in wild-type A549 cell lysates with no signal observed at this size in MYD88 knockout cell line Human MYD88 knockout A549 cell line ab286715 (knockout cell lysate ab290793). To generate this image, wild-type and MYD88 knockout A549 cell lysates were analysed. First, samples were run on an SDS-PAGE gel then transferred onto a nitrocellulose membrane. Membranes were blocked in 5% milk in TBS-0.1% Tween® 20 (TBS-T) before incubation with primary antibodies overnight at 4°C. Blots were washed four times in TBS-T, incubated with secondary antibodies for 1 h at room temperature, washed again four times then imaged. Secondary antibodies used were Goat anti-Rabbit IgG H&L 800CW and Goat anti-Mouse IgG H&L 680RD at 1/20000 dilution.

    All lanes: Western blot - Anti-MyD88 antibody (ab2064) at 1/1000 dilution

    Lane 1: Wild-type A549 cell lysate at 20 µg

    Lane 2: MYD88 knockout A549 cell lysate at 20 µg

    Lane 3: HEK-293 cell lysate at 20 µg

    Performed under reducing conditions.

    Observed band size: 35 kDa

  • Western blot - Anti-MyD88 antibody (ab2064), expandable thumbnail
    This image is courtesy of an anonymous customer review

    Western blot - Anti-MyD88 antibody (ab2064)

    All lanes: Western blot - Anti-MyD88 antibody (ab2064) at 1 µg/mL

    Lanes 1 - 2: Wild type MEFs whole cell lysate

    Lanes 3 - 4: MyD88 knockout MEFs whole cell lysate

    Secondary

    All lanes: HRP-conjugated goat anti-rabbit IgG polyclonal at 1/10000 dilution

    Developed using the ECL technique.

    Performed under reducing conditions.

    Predicted band size: 33 kDa

    Observed band size: 33 kDa

    Exposure time: 15s

  • Western blot - Anti-MyD88 antibody (ab2064), expandable thumbnail

    Western blot - Anti-MyD88 antibody (ab2064)

    All lanes: Western blot - Anti-MyD88 antibody (ab2064) at 2 µg/mL

    Lane 1: A549 cell lysate at 15 µg

    Lane 2: HepG2 cell lysate at 15 µg

    Lane 3: K562 cell lysate at 15 µg

    Lane 4: HT29 cell lysate at 15 µg

    Lane 5: HEK293 cell lysate at 15 µg

    Secondary

    All lanes: Goat anti-rabbit IgG HRP conjugate at 1/10000 dilution

    Predicted band size: 33 kDa

  • Immunocytochemistry/ Immunofluorescence - Anti-MyD88 antibody (ab2064), expandable thumbnail

    Immunocytochemistry/ Immunofluorescence - Anti-MyD88 antibody (ab2064)

    Immunocytochemistry/ Immunofluorescence analysis of 4% paraformaldehyde fixed Jurkat cells labeling MyD88 with ab2064 at 20 μg/mL, followed by goat anti-rabbit IgG secondary antibody at 1/500 dilution (green) and DAPI staining (blue).

  • Immunocytochemistry/ Immunofluorescence - Anti-MyD88 antibody (ab2064), expandable thumbnail

    Immunocytochemistry/ Immunofluorescence - Anti-MyD88 antibody (ab2064)

    Immunocytochemistry/ Immunofluorescence analysis of 4% paraformaldehyde fixed K562 cells labeling MyD88 with ab2064 at 20 μg/mL, followed by goat anti-rabbit IgG secondary antibody at 1/500 dilution (green) and DAPI staining (blue).

  • Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-MyD88 antibody (ab2064), expandable thumbnail

    Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-MyD88 antibody (ab2064)

    MyD88 Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) staining of Human Colon tissue using rabbit Anti-MyD88 antibody

    Immunohistochemical analysis of paraffin-embedded human colon tissue using anti-MYD88 antibody (ab2064) at 1 µg/ml. Tissue was fixed with formaldehyde and blocked with 10% serum for 1 h at RT; antigen retrieval was by heat mediation with a citrate buffer (pH6). Samples were incubated with primary antibody overnight at 4°C. A goat anti-rabbit IgG H&L (HRP) at 1/250 was used as secondary. Counter stained with Hematoxylin.

  • Immunocytochemistry/ Immunofluorescence - Anti-MyD88 antibody (ab2064), expandable thumbnail

    Immunocytochemistry/ Immunofluorescence - Anti-MyD88 antibody (ab2064)

    Immunofluorescent analysis of methanol-fixed HeLa cells labeling MyD88 with ab2064 at 20 μg/mL, followed by goat anti-rabbit IgG secondary antibody at 1/1000 dilution (red) and Hoechst staining (blue). Alpha tubulin was stained with anti-alpha tubulin antibody following by goat anti-mouse IgG secondary antibody (green).

  • Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-MyD88 antibody (ab2064), expandable thumbnail

    Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-MyD88 antibody (ab2064)

    MyD88 Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) staining of Mouse heart tissue using rabbit Anti-MyD88 antibody

    Immunohistochemical analysis of paraffin-embedded mouse heart tissue using anti-MYD88 antibody (ab2064) at 2 µg/ml. Tissue was fixed with formaldehyde and blocked with 10% serum for 1 h at RT; antigen retrieval was by heat mediation with a citrate buffer (pH6). Samples were incubated with primary antibody overnight at 4°C. A goat anti-rabbit IgG H&L (HRP) at 1/250 was used as secondary. Counter stained with Hematoxylin.

  • Western blot - Anti-MyD88 antibody (ab2064), expandable thumbnail

    Western blot - Anti-MyD88 antibody (ab2064)

    1 h incubation at RT in 5% NFDM/TBST.

    All lanes: Western blot - Anti-MyD88 antibody (ab2064) at 2 µg/mL

    Lane 1: WT HeLa Cells at 10 µg

    Lane 2: MyD88 knockout HeLa Cells at 10 µg

    Secondary

    All lanes: Goat Anti-Rabbit IgG HRP conjugate at 1/10000 dilution

    Predicted band size: 33 kDa

  • Western blot - Anti-MyD88 antibody (ab2064), expandable thumbnail

    Western blot - Anti-MyD88 antibody (ab2064)

    1 h incubation at RT in 5% NFDM/TBST.

    beta-actin was used as a loading control at 1 µg/mL.

    All lanes: Western blot - Anti-MyD88 antibody (ab2064) at 2 µg/mL

    Lane 1: HeLa WT cell lysate at 10 µg

    Lane 2: MyD88 KO HeLa cell lysate at 10 µg

    Secondary

    All lanes: Goat Anti-Rabbit IgG HRP conjugate at 1/10000 dilution

    Predicted band size: 33 kDa

Downloads

Product protocols

For this product, it's our understanding that no specific protocols are required. You can:

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com